VATTEMI, Gaetano Nicola
 Distribuzione geografica
Continente #
NA - Nord America 4.920
EU - Europa 4.559
AS - Asia 3.076
SA - Sud America 511
AF - Africa 74
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 2
AN - Antartide 1
Totale 13.148
Nazione #
US - Stati Uniti d'America 4.837
RU - Federazione Russa 1.867
SG - Singapore 1.238
CN - Cina 1.018
GB - Regno Unito 889
BR - Brasile 442
DE - Germania 334
HK - Hong Kong 284
SE - Svezia 262
FR - Francia 255
IT - Italia 251
FI - Finlandia 246
IE - Irlanda 199
VN - Vietnam 187
KR - Corea 99
UA - Ucraina 82
CA - Canada 49
TR - Turchia 48
IN - India 47
NL - Olanda 31
ID - Indonesia 30
JP - Giappone 29
BE - Belgio 28
PL - Polonia 28
AR - Argentina 27
MX - Messico 26
ZA - Sudafrica 23
ES - Italia 22
BD - Bangladesh 20
AT - Austria 18
IQ - Iraq 15
RO - Romania 13
PK - Pakistan 12
BJ - Benin 9
CL - Cile 8
EC - Ecuador 8
MA - Marocco 8
TG - Togo 8
KE - Kenya 7
IL - Israele 6
LT - Lituania 6
PY - Paraguay 6
UY - Uruguay 6
VE - Venezuela 6
AE - Emirati Arabi Uniti 5
CH - Svizzera 5
DO - Repubblica Dominicana 5
UZ - Uzbekistan 5
CO - Colombia 4
EG - Egitto 4
GR - Grecia 4
PE - Perù 4
AM - Armenia 3
AU - Australia 3
AZ - Azerbaigian 3
BG - Bulgaria 3
DZ - Algeria 3
JO - Giordania 3
KZ - Kazakistan 3
LB - Libano 3
MY - Malesia 3
NP - Nepal 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AL - Albania 2
CI - Costa d'Avorio 2
KG - Kirghizistan 2
LV - Lettonia 2
MU - Mauritius 2
OM - Oman 2
PH - Filippine 2
PS - Palestinian Territory 2
PT - Portogallo 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
TN - Tunisia 2
AQ - Antartide 1
CD - Congo 1
CG - Congo 1
CZ - Repubblica Ceca 1
DM - Dominica 1
EE - Estonia 1
GN - Guinea 1
HN - Honduras 1
IR - Iran 1
IS - Islanda 1
KW - Kuwait 1
LU - Lussemburgo 1
ML - Mali 1
MT - Malta 1
NC - Nuova Caledonia 1
NZ - Nuova Zelanda 1
QA - Qatar 1
SA - Arabia Saudita 1
SI - Slovenia 1
TT - Trinidad e Tobago 1
Totale 13.148
Città #
Dallas 956
Southend 740
Moscow 683
Singapore 602
Chandler 552
Jacksonville 496
Woodbridge 379
Ashburn 332
Hong Kong 283
Beijing 208
Ann Arbor 202
Dublin 199
Houston 181
Munich 141
New York 120
Verona 120
The Dalles 96
Los Angeles 91
Wilmington 83
Lawrence 82
Princeton 82
Helsinki 80
Jinan 78
Ho Chi Minh City 68
Shenyang 66
Nanjing 61
São Paulo 43
Columbus 41
Tianjin 37
Hebei 36
Hanoi 34
Buffalo 31
Redondo Beach 31
Santa Clara 31
Brussels 27
Haikou 27
Turku 27
Seattle 26
Seoul 26
Sindelfingen 26
Boardman 25
London 25
Warsaw 25
Orem 23
Tokyo 23
Hangzhou 22
Jakarta 22
Nanchang 21
Ningbo 21
Changsha 20
Chicago 20
Denver 20
Guangzhou 20
Milan 20
Taizhou 20
Johannesburg 19
Taiyuan 19
Toronto 19
Chennai 18
Jiaxing 18
Nuremberg 18
Zhengzhou 18
Dearborn 17
Amsterdam 16
Poplar 16
Council Bluffs 15
Phoenix 15
Montreal 14
Fuzhou 13
Lappeenranta 13
Stockholm 13
Norwalk 12
San Francisco 12
Atlanta 11
Bologna 11
Haiphong 11
Kent 11
Redwood City 11
Rio de Janeiro 11
Washington 11
Brooklyn 10
Frankfurt am Main 10
Redmond 10
Belo Horizonte 9
Cotonou 9
Falkenstein 9
Lancaster 9
Vienna 9
Lomé 8
Manchester 8
Mexico City 8
San Jose 8
Ankara 7
Boston 7
Clearwater 7
Da Nang 7
Falls Church 7
Nairobi 7
New Delhi 7
Riva 7
Totale 8.276
Nome #
A mutation in the CASQ1 gene causes a vacuolar myopathy with accumulation of sarcoplasmic reticulum protein aggregates. 291
Abnormal expression of RNA polymerase II associated proteins in muscle of patients with myofibrillar myopathies. 245
Acute inflammatory demyelinating polyneuropathy as a manifestation of chronic lymphoproliferative disorder of NK cells. 225
Overexpression of TNF-α in mitochondrial diseases caused by mutations in mtDNA: evidence for signaling through its receptors on mitochondria. 223
Differential regulation of TNF receptors in maternal leukocytes is associated with severe preterm preeclampsia. 204
Levofloxacin-induced hemichorea-hemiballism in a patient with previous thalamic infarction 201
Bortezomib-induced muscle toxicity in multiple myeloma 199
Increased protein nitration in mitochondrial diseases: evidence for vessel wall involvement. 198
BACE1 and BACE2 in pathologic and normal human muscle 196
8C.05: EPOXYEICOSATRIENOIC ACIDS ARE INCREASED IN PLACENTAS OF PREECLAMPTIC PREGNANCIES 192
Antioxidant agents have a different expression pattern in muscle fibers of patients with mitochondrial diseases 191
Anti-Ma-associated encephalomyeloradiculopathy in a patient with pleural mesothelioma. 188
Benign acute viral myositis in African migrants: a clinical, serological and pathological study. 188
Autophagy, inflammation and innate immunity in inflammatory myopathies. 185
Endothelial dysfunction and increased oxidative stress in mitochondrial diseases. 177
Pisa syndrome in Parkinson's disease: an electrophysiological and imaging study. 176
Evidence for caspase-dependent programmed cell death along with repair processes in affected skeletal muscle fibres in patients with mitochondrial disorders 175
Chronic graft-versus-host-disease-related polymyositis: a 17-months-old child with a rare and late complication of haematopoietic stem cell transplantation 173
McArdle disease and sporadic inclusion-body myositis. 168
Brody Disease: insights into biochemical features of SERCA1 and identification of a novel mutation. 166
Selective pseudohypertrophy of vastus medialis muscles associated with calpain 3 deficiency. 166
Adult-onset muscular dystrophy in a cat associated with a presumptive alteration in trafficking of caveolin-3. 165
Autoantibody testing in patients with myositis: clinical accuracy of a multi parametric line immunoassay 163
Amyloid myopathy: an intriguing diagnosis 162
A novel emerin gene mutation in Emery Dreifuss muscular dystrophy patient with spontaneous chordae tendinae rupture 161
A new mutation in the mitochondrial tRNA(Ala) gene in a patient with ophthalmoplegia and dysphagia 160
Amyloid-beta42 is preferentially accumulated in muscle fibers of patients with sporadic inclusion-body myositis. 160
Brody syndrome: A clinically heterogeneous entity distinct from Brody disease: A review of literature and a cross-sectional clinical study in 17 patients. 160
Calpain 3 deficiency presenting as fiber type disproportion. 158
Endothelial dysfunction in mitochondrial diseases: biological and biochemical evidence of increased oxidative stress and peroxinitrite generation 158
Characterization of sarcoplasmic reticulum Ca(2+) ATPase pumps in muscle of patients with myotonic dystrophy and with hypothyroid myopathy 157
A novel in-frame deletion in MYOT causes an early adult onset distal myopathy 155
A novel de novo GFAP variant causes a juvenile-onset Alexander disease with bilateral vocal cord paralysis 152
Advanced cellular models for rare disease study: exploring neural, muscle and skeletal organoids 152
Increased expression of the normal cellular isoform of prion protein in inclusion-body myositis, inflammatory myopathies and denervation atrophy 150
Muscular dystrophy with reduced beta-sarcoglycan in a cat. 150
Acute sarcomeric M-Line Disease associated with ATP synthase subunit α autoantibodies in ankylosing spondylitis 150
Immunoblot as a potential diagnostic tool for myofibrillar myopathies 149
SERCA1 protein expression in muscle of patients with Brody disease and Brody syndrome and in cultured human muscle fibers. 148
Clinical, morphological and genetic studies in a cohort of 21 patients with myofibrillar myopathy. 147
Polymyositis in solid organ transplant recipients receiving tacrolimus. 147
Chronic ophthalmoparesis in limb girdle muscular dystrophy 1C. 147
The role of muscle biopsy in investigating isolated muscle pain 146
Cutis verticis gyrata, mental retardation and Lennox-Gastaut syndrome: a case report 145
T-cell anti-apoptotic mechanisms in inflammatory myopathies 144
Increased epoxyeicosatrienoic acids and reduced soluble epoxide hydrolase expression in the preeclamptic placenta 144
Programmed cell death occurs in muscle fibers with mitochondrial dysfunction 143
Human skeletal muscle as a target organ of trichloroethylene toxicity. 143
Non-hematologic toxicity of bortezomib in multiple myeloma: the neuromuscular and cardiovascular adverse effects 142
Evidence of ER stress and UPR activation in patients with Brody disease and Brody syndrome 139
Expanding the clinical and genetic spectrum of pathogenic variants in STIM1 138
Transcription factors c-Jun/activator protein-1 and nuclear factor-kappa B in oxidative stress response in mithocondrial diseases 135
Expression of Protein Kinase C isoforms and interleukin-1beta in myofibrillar myopathy 133
Sarcoidosis and inclusion body myositis. 132
Pearls & Oy-sters: An unusual case of varicella-zoster virus cerebellitis and vasculopathy. 132
Multiple acyl-COA dehydrogenase deficiency in elderly carriers 131
Transthyretin Val122Ile, accumulated Aβ, and inclusion-body myositis aspects in cultured muscle 129
SERCA1 and calsequestrin storage myopathy: a new surplus protein myopathy. 126
Clinical, morphological and genetic characterization of Brody disease: an international study of 40 patients 125
Acetylcholine receptor-antibody-positive myasthenia gravis presenting with early atrophy and nonfluctuating weakness of proximal limb muscles 124
Reversible upper limb muscle weakness with selective loss of thick filaments 122
Protein expression of canine and feline muscular dystrophies 121
Whole-exome sequencing in patients with protein aggregate myopathies reveals causative mutations associated with novel atypical phenotypes 120
Neuropathology of mitochondrial diseases 120
Cationic PMMA nanoparticles bind and deliver antisense oligoribonucleotides allowing restoration of dystrophin expression in the mdx mouse. 119
Relapsing-remitting painful masses of the skeletal muscle 117
Upper camptocormia in Parkinson's disease: Neurophysiological and imaging findings of both central and peripheral pathophysiological mechanisms 117
Cystatin C colocalizes with amyloid-beta and coimmunoprecipitates with amyloid-beta precursor protein in sporadic inclusion-body myositis muscles 116
Persistent dystrophin protein restoration 90 days after a course of intraperitoneally administered naked 2'OMePS AON and ZM2 NP-AON complexes in mdx mice. 114
Expression of late myogenic differentiation markers in sarcoplasmic masses of patients with myotonic dystrophy 111
Endoplasmic reticulum stress and unfolded protein response in inclusion body myositis muscle. 108
Mutant ubiquitin UBB+1 is accumulated in sporadic inclusion-body myositis muscle fibers 104
Presence of BACE1 and BACE2 in muscle fibres of patients with sporadic inclusion-body myositis 104
Human mutated MYOT and CRYAB genes cause a myopathic phenotype in Zebrafish 103
Dermatomyositis and retroperitoneal germ cell cancer 102
Riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency: delayed hypersensitivity reaction and efficacy of low-dose intermittent supplementation 102
Identification and characterization of three novel mutations in the CASQ1 gene in four patients with tubular aggregate myopathy 101
Neuronal intermediate filament paraneoplastic autoimmunity complicating avelumab therapy of Merkel cell carcinoma 100
Dystrophin restoration in skeletal, heart and skin arrector pili smooth muscle of mdx mice by ZM2 NP-AON complexes. 99
Muscle biopsy features of idiopathic inflammatory myopathies and differential diagnosis 98
Eyelid ptosis from sympathetic nerve dysfunction mistaken as myopathy: a simple test to identify this condition 96
Uptake and intracellular distribution of different types of nanoparticles in primary human myoblasts and myotubes 96
Transcriptional behavior of DMD gene duplications in DMD/BMD males. 91
Ryanodine receptor 1 (RYR1) mutations in two patients with tubular aggregate myopathy 87
Novel mitochondrial tRNA(Leu(CUN)) transition and D4Z4 partial deletion in a patient with a facioscapulohumeral phenotype 85
Diagnostic performance and validation of autoantibody testing in myositis by a commercial line blot assay. 82
Profibrotic Molecules Are Reduced in CRISPR-Edited Emery–Dreifuss Muscular Dystrophy Fibroblasts 80
Analysis of the Italian cohort of late-onset Pompe disease (LOPD) patients after 10 and 15 years of therapy with alglucosidase alfa 80
Physical training promotes remodeling of the skeletal muscle extracellular matrix: An ultrastructural study in a murine model of Down syndrome 80
Neurogenic disease with high CK: think muscle 70
Sporadic inclusion body myositis at the crossroads between muscle degeneration, inflammation, and aging 58
Physical activity practiced at a young age is associated with a less severe subsequent clinical presentation in facioscapulohumeral muscular dystrophy 57
Premature skeletal muscle aging in VPS13A deficiency relates to impaired autophagy 56
The FSHD jigsaw: are we placing the tiles in the right position? 56
Clinical, Histopathologic, and Genetic Features of Patients With Myofibrillary and Distal Myopathies: Experience From the Italian Network 51
Toll-like receptors and IL-7 as potential biomarkers for immune-mediated necrotizing myopathies 45
Evaluation of aggrephagy markers in myofibrillar myopathies 41
Nucleolar FRG2 lncRNAs inhibit rRNA transcription and cytoplasmic translation, linking FSHD to dysregulation of muscle-specific protein synthesis 38
Case Report: Simultaneous presentation of end-stage heart failure with cardiogenic shock requiring emergency transplantation in monozygotic twins with myofibrillar myopathy: a previously unknown genetic disease? 13
Totale 13.289
Categoria #
all - tutte 42.990
article - articoli 42.051
book - libri 0
conference - conferenze 939
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 85.980


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021295 0 0 0 0 0 83 11 49 43 12 83 14
2021/2022715 86 275 2 47 18 13 8 38 17 12 48 151
2022/20231.474 113 166 143 233 154 329 14 89 177 11 23 22
2023/2024724 29 74 54 73 77 134 27 70 10 44 83 49
2024/20252.324 104 108 80 340 129 112 197 146 366 133 183 426
2025/20264.894 418 692 587 1.103 1.714 380 0 0 0 0 0 0
Totale 13.289